Effects of Adjuvant Radiotherapy for Testicular Cancer on CD4+ Cell Count in HIV-Positive Patients: A Case Report

AIDS Reader

Volumn 14, Issue 4, 2004, Pages

  Harshany, Mark L ^a   Polhemus, Mark E ^b  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Cancer, testicular, seminoma; HIV AIDS; Radiotherapy

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CASE REPORT; DISEASE ACTIVITY; DISEASE COURSE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LEUKOCYTE; LYMPHOCYTE COUNT; MALE; ORCHIECTOMY; RADIATION DOSE; RADIATION SICKNESS; RISK FACTOR; SEMINOMA; SEXUAL BEHAVIOR; TESTIS CANCER; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HUMANS; MALE; RADIOTHERAPY, ADJUVANT; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 16544373509     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Powles T, Bower M, Daugaard G, et al. Multicenter study of human immunodeficiency virus-related germ cell tmnors. J Clin Oncol. 2003;21:1922-1927.
2. Jerome P, Richie JP, Steele GS. Neoplasms of the testis. In: Walsh PC, Retik AB, Vaughan ED Jr, et al, eds. Campbell's Urology. 8th ed. New York: Elsevier; 2002:chap 81.
3. Bauman GS, Venkatesan VM, Ago CT, et al. Postoperative radiotherapy for stage I/II seminoma: results for 212 patients. Int J Radiat Oncol Biol Phys. 1998;42:313-317.
4. Melchior D, Hammer P, Fimmers R, et al. Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma. Anticancer Res. 2001;21(4B): 2989-2993.
5. Bussieres E, Richaud P, Gualde N. Intra-operative electron beam radiotherapy and abdomino-pelvic surgery for cancer: influence on immunological parameters. Eur J Surg Oncol. 1992;18:425-432.
6. De Ruysscher D, Waer M, Vandeputte M, et al. Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: long-term increase of activated (HLA-DR+) T cells and decrease of "naive" (CD4-CD45R) T lymphocytes. Eur J Cancer. 1992;28A:1729-1734.
7. Timmerman JM, Northfelt DW, Small EJ. Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy. J Clin Oncol. 1995;13:1391-1397.
8. Fizazi K, Amato RJ, Beuzeboc P, et al. Germ cell tumors in patients infected by the human immunodeficiency virus. Cancer. 2001;92:1460-1467.
9. + T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis. 2002;185:905-914.
10. Laurence J. T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia. Ann Intern Med. 1993;119:55-62.
11. Bast RC Jr, Reinherz EL, Maver C, et al. Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes. Clin Immunol Immunopathol. 1983;28:101-114.
12. Wilkinson M, Carroll PR. Testicular carcinoma in patients positive and at risk for human immunodeficiency virus. J Urol. 1990;144:1157-1159.